Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.
The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
- Legend
- PPalliative care items
- MPMedical Practitioner
- MWMidwife
- NPNurse Practitioner
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MPNP | 13522Q | BACLOFENbaclofen 10 mg tablet, 100 | 2 | 200 | 5 |
MPNP | 2729P | BACLOFENbaclofen 10 mg tablet, 100 | 1 | 100 | 5 |
MPNP | 13359D | BACLOFENbaclofen 25 mg tablet, 100 | 2 | 200 | 5 |
MPNP | 2730Q | BACLOFENbaclofen 25 mg tablet, 100 | 1 | 100 | 5 |
MPNP | 11351K | BALSALAZIDEbalsalazide sodium 750 mg capsule, 280 | 1 | 280 | 5 |
MPNP | 13484Q | BALSALAZIDEbalsalazide sodium 750 mg capsule, 280 | 2 | 560 | 5 |
MPNP | 8409N | BECLOMETASONEbeclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations | 1 | 1 | 5 |
MPNP | 8408M | BECLOMETASONEbeclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations | 1 | 1 | 5 |
MPNP | 8406K | BECLOMETASONEbeclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations | 1 | 1 | 5 |
MPNP | 8407L | BECLOMETASONEbeclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations | 1 | 1 | 5 |
MPNP | 12183F | BECLOMETASONE + FORMOTEROLbeclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 13205B | BECLOMETASONE + FORMOTEROLbeclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 12468F | BECLOMETASONE + FORMOTEROL + GLYCOPYRRONIUMbeclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 13200R | BECLOMETASONE + FORMOTEROL + GLYCOPYRRONIUMbeclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 11755Q | BENZATHINE BENZYLPENICILLINbenzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 10 x 2.3 mL syringes | 1 | 10 | 0 |
MPNP | 2267H | BENZATHINE BENZYLPENICILLINbenzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, 10 x 2.3 mL syringes | 1 | 10 | 0 |
MPNP | 13801J | BENZATHINE BENZYLPENICILLINbenzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack | 10 | 10 | 0 |
MPNP | 13816E | BENZATHINE BENZYLPENICILLINbenzathine benzylpenicillin 1.2 million units powder for injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack | 10 | 10 | 0 |
MPNP | 11723B | BENZATHINE BENZYLPENICILLINbenzathine benzylpenicillin tetrahydrate 600 000 units (517 mg)/1.17 mL injection, 10 x 1.17 mL syringes | 1 | 10 | 0 |
MPNP | 11255J | BENZATROPINEbenzatropine mesilate 2 mg/2 mL injection, 5 x 2 mL vials | 1 | 5 | 0 |
MPNP | 11265X | BENZATROPINEbenzatropine mesilate 2 mg/2 mL injection, 5 x 2 mL vials | 1 | 5 | 0 |
MPNP | 2362H | BENZATROPINEbenzatropine mesilate 2 mg tablet, 60 | 1 | 60 | 2 |
MPNP | 1121B | BENZYDAMINEbenzydamine hydrochloride 0.15% mouthwash, 500 mL | 1 | 1 | 1 |
MPNP | 5385K | BENZYDAMINEbenzydamine hydrochloride 0.15% mouthwash, 500 mL | 1 | 1 | 3 |
MPNP | 2647H | BENZYLPENICILLINbenzylpenicillin 3 g injection, 1 vial | 10 | 10 | 0 |
MPNP | 3487M | BENZYLPENICILLINbenzylpenicillin 3 g injection, 1 vial | 1 | 1 | 0 |
MPMWNP | 1775K | BENZYLPENICILLINbenzylpenicillin 600 mg injection, 1 vial | 10 | 10 | 1 |
MPNP | 3486L | BENZYLPENICILLINbenzylpenicillin 600 mg injection, 1 vial | 5 | 5 | 0 |
MPNP | 2694T | BETAMETHASONE ACETATE + BETAMETHASONE SODIUM PHOSPHATEbetamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, 5 x 1 mL ampoules | 1 | 5 | 0 |
MPNP | 1115Q | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g | 1 | 1 | 1 |
MPNP | 10824Q | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g | 2 | 2 | 5 |
MPNP | 10800K | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g | 4 | 4 | 5 |
MPNP | 10813D | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g | 6 | 6 | 5 |
MPNP | 10801L | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g | 8 | 8 | 5 |
MPNP | 10802M | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g | 10 | 10 | 5 |
MPNP | 1119X | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g | 1 | 1 | 1 |
MPNP | 10795E | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g | 2 | 2 | 5 |
MPNP | 10820L | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g | 4 | 4 | 5 |
MPNP | 10821M | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g | 6 | 6 | 5 |
MPNP | 10816G | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g | 8 | 8 | 5 |
MPNP | 10823P | BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g | 10 | 10 | 5 |
MPNP | 2812B | BETAMETHASONE VALERATEbetamethasone (as valerate) 0.02% cream, 100 g | 2 | 2 | 0 |
MPNP | 2813C | BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g | 1 | 1 | 1 |
MPNP | 10799J | BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g | 2 | 2 | 5 |
MPNP | 10794D | BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g | 4 | 4 | 5 |
MPNP | 10808W | BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g | 6 | 6 | 5 |
MPNP | 10807T | BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g | 8 | 8 | 5 |
MPNP | 10810Y | BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g | 10 | 10 | 5 |
MPNP | 1062X | BETHANECHOLbethanechol chloride 10 mg tablet, 100 | 1 | 100 | 2 |
MPNP | 8094B | BICALUTAMIDEbicalutamide 50 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13933H | BICARBONATEsodium bicarbonate 840 mg capsule, 100 | 2 | 200 | 2 |
MPNP | 9470K | BICARBONATEsodium bicarbonate 840 mg capsule, 100 | 1 | 100 | 2 |
MPNP | 11649D | BICTEGRAVIR + EMTRICITABINE + TENOFOVIR ALAFENAMIDEbictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 1259G | BISACODYLbisacodyl 5 mg enteric tablet, 200 | 1 | 200 | 2 |
MPNP | 1263L | BISACODYLbisacodyl 10 mg/5 mL enema, 25 x 5 mL | 1 | 1 | 2 |
MPNP | 1260H | BISACODYLbisacodyl 10 mg suppository, 10 | 3 | 3 | 5 |
MPNP | 1258F | BISACODYLbisacodyl 10 mg suppository, 12 | 3 | 3 | 4 |
MPNP | 13444N | BISOPROLOLbisoprolol fumarate 10 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8606Y | BISOPROLOLbisoprolol fumarate 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13419G | BISOPROLOLbisoprolol fumarate 2.5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8604W | BISOPROLOLbisoprolol fumarate 2.5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13443M | BISOPROLOLbisoprolol fumarate 5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8605X | BISOPROLOLbisoprolol fumarate 5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 11189X | BREXPIPRAZOLEbrexpiprazole 1 mg tablet, 30 | 1 | 30 | 0 |
MPNP | 11188W | BREXPIPRAZOLEbrexpiprazole 2 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 11190Y | BREXPIPRAZOLEbrexpiprazole 3 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 11184P | BREXPIPRAZOLEbrexpiprazole 4 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 11358T | BRIVARACETAMbrivaracetam 10 mg/mL oral liquid, 300 mL | 1 | 1 | 5 |
MPNP | 11357R | BRIVARACETAMbrivaracetam 100 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 11327E | BRIVARACETAMbrivaracetam 25 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 11338R | BRIVARACETAMbrivaracetam 50 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 11350J | BRIVARACETAMbrivaracetam 75 mg tablet, 56 | 1 | 56 | 5 |
MPNP | 1444B | BROMOCRIPTINEbromocriptine 2.5 mg tablet, 30 | 1 | 30 | 0 |
MPNP | 2072C | BUDESONIDEbudesonide 400 microgram/actuation powder for inhalation, 200 actuations | 1 | 1 | 5 |
MPNP | 12915R | BUDESONIDEbudesonide 3 mg modified release capsule, 90 | 1 | 90 | 2 |
MPNP | 10034D | BUDESONIDEbudesonide 2 mg/application foam, 2 x 14 applications | 1 | 1 | 3 |
MPNP | 2066R | BUDESONIDEbudesonide 1 mg/2 mL inhalation solution, 30 x 2 mL ampoules | 1 | 1 | 5 |
MPNP | 2065Q | BUDESONIDEbudesonide 500 microgram/2 mL inhalation solution, 30 x 2 mL ampoules | 1 | 1 | 5 |
MPNP | 2070Y | BUDESONIDEbudesonide 100 microgram/actuation powder for inhalation, 200 actuations | 1 | 1 | 5 |
MPNP | 2071B | BUDESONIDEbudesonide 200 microgram/actuation powder for inhalation, 200 actuations | 1 | 1 | 5 |
MPNP | 10024N | BUDESONIDE + FORMOTEROLbudesonide 50 microgram/actuation + formoterol fumarate dihydrate 3 microgram/actuation inhalation, 120 actuations | 2 | 2 | 5 |
MPNP | 10015D | BUDESONIDE + FORMOTEROLbudesonide 100 microgram/actuation + formoterol fumarate dihydrate 3 microgram/actuation inhalation, 120 actuations | 2 | 2 | 5 |
MPNP | 12042T | BUDESONIDE + FORMOTEROLbudesonide 100 microgram/actuation + formoterol fumarate dihydrate 3 microgram/actuation inhalation, 120 actuations | 2 | 2 | 2 |
MPNP | 10018G | BUDESONIDE + FORMOTEROLbudesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, 120 actuations | 2 | 2 | 5 |
MPNP | 8796Y | BUDESONIDE + FORMOTEROLbudesonide 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 11273H | BUDESONIDE + FORMOTEROLbudesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 12029D | BUDESONIDE + FORMOTEROLbudesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations | 1 | 1 | 2 |
MPNP | 12041R | BUDESONIDE + FORMOTEROLbudesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations | 1 | 1 | 2 |
MPNP | 8625Y | BUDESONIDE + FORMOTEROLbudesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 11301T | BUDESONIDE + FORMOTEROLbudesonide 400 microgram/actuation + formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation, 2 x 60 actuations | 1 | 2 | 5 |
MPNP | 13258T | BUDESONIDE + FORMOTEROLbudesonide 400 microgram/actuation + formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation, 60 actuations | 2 | 2 | 5 |
MPNP | 12672Y | BUDESONIDE + GLYCOPYRRONIUM + FORMOTEROLbudesonide 160 microgram/actuation + glycopyrronium 7.2 microgram/actuation + formoterol fumarate dihydrate 5 microgram/actuation inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 13336X | BUPRENORPHINEbuprenorphine 2 mg sublingual tablet, 7 | 12 | 84 | 2 |
MPNP | 13337Y | BUPRENORPHINEbuprenorphine 8 mg sublingual tablet, 7 | 16 | 112 | 2 |
MPNP | 10746N | BUPRENORPHINEbuprenorphine 40 microgram/hour patch, 2 | 1 | 2 | 0 |
MPNP | 10959T | BUPRENORPHINEbuprenorphine 40 microgram/hour patch, 2 | 2 | 4 | 0 |
MPNP | 13302D | BUPRENORPHINEbuprenorphine 128 mg/0.36 mL modified release injection, 0.36 mL syringe | 1 | 1 | 2 |
MPNP | 13297W | BUPRENORPHINEbuprenorphine 16 mg/0.32 mL modified release injection, 0.32 mL syringe | 4 | 4 | 2 |
MPNP | 13296T | BUPRENORPHINEbuprenorphine 24 mg/0.48 mL modified release injection, 0.48 mL syringe | 4 | 4 | 2 |
MPNP | 10948F | BUPRENORPHINEbuprenorphine 10 microgram/hour patch, 2 | 2 | 4 | 0 |
MPNP | 8866P | BUPRENORPHINEbuprenorphine 10 microgram/hour patch, 2 | 1 | 2 | 0 |
MPNP | 13303E | BUPRENORPHINEbuprenorphine 160 mg/0.45 mL modified release injection, 0.45 mL syringe | 1 | 1 | 2 |
MPNP | 10970J | BUPRENORPHINEbuprenorphine 20 microgram/hour patch, 2 | 2 | 4 | 0 |
MPNP | 8867Q | BUPRENORPHINEbuprenorphine 20 microgram/hour patch, 2 | 1 | 2 | 0 |
MPNP | 10957Q | BUPRENORPHINEbuprenorphine 5 microgram/hour patch, 2 | 2 | 4 | 0 |
MPNP | 8865N | BUPRENORPHINEbuprenorphine 5 microgram/hour patch, 2 | 1 | 2 | 0 |
MPNP | 13310M | BUPRENORPHINEbuprenorphine 400 microgram sublingual tablet, 7 | 4 | 28 | 2 |
MPNP | 10770W | BUPRENORPHINEbuprenorphine 15 microgram/hour patch, 2 | 1 | 2 | 0 |
MPNP | 10953L | BUPRENORPHINEbuprenorphine 15 microgram/hour patch, 2 | 2 | 4 | 0 |
MPNP | 13314R | BUPRENORPHINEbuprenorphine 32 mg/0.64 mL modified release injection, 0.64 mL syringe | 4 | 4 | 2 |
MPNP | 13298X | BUPRENORPHINEbuprenorphine 64 mg/0.18 mL modified release injection, 0.18 mL syringe | 1 | 1 | 2 |
MPNP | 13328L | BUPRENORPHINEbuprenorphine 8 mg/0.16 mL modified release injection, 0.16 mL syringe | 4 | 4 | 2 |
MPNP | 10756D | BUPRENORPHINEbuprenorphine 25 microgram/hour patch, 2 | 1 | 2 | 0 |
MPNP | 10964C | BUPRENORPHINEbuprenorphine 25 microgram/hour patch, 2 | 2 | 4 | 0 |
MPNP | 10755C | BUPRENORPHINEbuprenorphine 30 microgram/hour patch, 2 | 1 | 2 | 0 |
MPNP | 10949G | BUPRENORPHINEbuprenorphine 30 microgram/hour patch, 2 | 2 | 4 | 0 |
MPNP | 13309L | BUPRENORPHINEbuprenorphine 96 mg/0.27 mL modified release injection, 0.27 mL syringe | 1 | 1 | 2 |
MPNP | 13320C | BUPRENORPHINEbuprenorphine 100 mg/0.5 mL modified release injection, 0.5 mL syringe | 1 | 1 | 2 |
MPNP | 13327K | BUPRENORPHINEbuprenorphine 300 mg/1.5 mL modified release injection, 1.5 mL syringe | 1 | 1 | 2 |
MPNP | 13322E | BUPRENORPHINE + NALOXONEbuprenorphine 2 mg + naloxone 500 microgram sublingual film, 28 | 3 | 84 | 2 |
MPNP | 13321D | BUPRENORPHINE + NALOXONEbuprenorphine 8 mg + naloxone 2 mg sublingual film, 28 | 4 | 112 | 2 |
MPNP | 8465M | BUPROPIONbupropion hydrochloride 150 mg modified release tablet, 30 | 1 | 30 | 0 |
MPNP | 8710K | BUPROPIONbupropion hydrochloride 150 mg modified release tablet, 90 | 1 | 90 | 0 |